BIOFACE PASSStandard Care Pathways in Facial Reconstruction Post Head and Neck Cancer Surgery
Data Collection
Collected from today forward - ProspectiveHead and Neck Neoplasms
+ Neoplasms
+ Neoplasms by Site
Case-Only
Examining characteristics of individuals with a disease in order to identify genetic or environmental factors contributing to the condition.Summary
Study start date: September 3, 2025
Actual date on which the first participant was enrolled.Curative management of head and neck cancers frequently requires an interrupting mandibulectomy or maxillectomy. Surgery may involve resection of anatomical structures such as jaw or maxilla. The use of free vascularized fibula or scapula flap is the "gold standard" for mandibular and maxillary reconstruction but remains suboptimal as resulting in difficulty in speaking, swallowing, and disfigurement. The BIOFACE project, funded by "Appel à Projet -Recherche Hospitalo-Universitaire en santé (RHU)" number 6 France 2023, aims to develop a new biomaterials based device to reconstruct these structure after surgery. In addition to the clinical benefits, this project aims to demonstrate the medico-economic benefits of the BIOFACE solution. Therefore, the Bioface PASS study has been designed to describe standard of care pathways of patients treated by free bone flap for facial reconstruction after surgery for head and neck cancer. Direct medical and non-medical costs, and daily allowance 12 months after the end of treatment, and quality of life will be recorded at the inclusion, 3 and 12 months. From the hospital perspectives, production costs will be recorded using the micro-costing approach.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.200 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Case-only
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Inclusion Criteria: * Patient with oral cavity cancer or maxillary and/or oropharynx cancer * Eligible for treatment by surgery requiring a mandibulectomy or segmental maxillectomy and having a free bone flap for facial reconstruction. * Patient whose disease is classified Stage cT4a, N0 to N3, M0 * Treatment with a feasible curative aim (no contraindication to optimal treatment such as surgery or chemotherapy at a curative dose) * Age greater than or equal to 18 years * Patient affiliated to a Social Security scheme in France * Patient having given written informed consent Non-inclusion Criteria: * Patient having any situation considered by the doctor as a reason for non-inclusion such as stenosis of the leg tripod not allowing reconstruction by fibula, one or more comorbidity(s) not allowing reconstruction by free bone flap or making this reconstruction too much risk * Patient having had previous radiotherapy * Patient with severe coagulation disorders * Patients deprived of liberty or under legal protection regime (curatorship and guardianship, safeguard of justice)
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.Study Objectives
Primary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 9 locations
University hospital of Amiens- Picardie
Amiens, FranceUniversity hospital of Lille
Lille, FranceHospices Civils de Lyon
Lyon, France